CE01-119: A Phase 1, Open-label, Multi-center Study to Determine the Pharmacokinetics and Safety of Solithromycin as Add-on Therapy in Adolescents with Suspected or Confirmed Bacterial Infection

Project: Research project

Project Details

StatusFinished
Effective start/end date2/1/1412/31/15

Funding

  • Duke University
  • Cempra Pharmaceuticals, Inc./ Federal Subcontract